Tang R, Lei Y, Ye L, Zhao G, Xiang X, Li G
Zhongguo Fei Ai Za Zhi. 2025; 27(12):911-918.
PMID: 39962846
PMC: 11839495.
DOI: 10.3779/j.issn.1009-3419.2024.101.33.
Zhao Q, Wang T
Am J Transl Res. 2024; 16(11):6615-6625.
PMID: 39678584
PMC: 11645618.
DOI: 10.62347/DTPQ4790.
Hu L, Liu M, Tang B, Li X, Xu H, Wang H
Cancer Gene Ther. 2024; 31(11):1696-1707.
PMID: 39300216
DOI: 10.1038/s41417-024-00829-w.
Zhang N, Zhang H, Liu Y
Medicine (Baltimore). 2024; 103(37):e39314.
PMID: 39287285
PMC: 11404940.
DOI: 10.1097/MD.0000000000039314.
Lin J, Yang X, Chen Q, Wang A, Arbing R, Chen W
Support Care Cancer. 2024; 32(4):211.
PMID: 38443746
DOI: 10.1007/s00520-024-08413-6.
Using Pharmacokinetic-Pharmacodynamic Modeling to Study the Main Active Substances of the Anticancer Effect in Mice from -.
Liu L, Lyu J, Yang L, Gao Y, Zhao B
Molecules. 2024; 29(2).
PMID: 38257247
PMC: 10819458.
DOI: 10.3390/molecules29020334.
The dyadic relationship of supportive care needs with quality of life in lung cancer survivor and spousal caregiver couples.
Weng Y, Lin J, Yang T, Lin Y, Chen H, Chen W
Asia Pac J Oncol Nurs. 2023; 10(11):100300.
PMID: 37908225
PMC: 10613913.
DOI: 10.1016/j.apjon.2023.100300.
Evolutionary game analysis of indoor radon mitigation with local government involvement.
Lin D, Zhuo W, Yao Y, Qiang Z, Chen B
Heliyon. 2023; 9(10):e20425.
PMID: 37790969
PMC: 10543230.
DOI: 10.1016/j.heliyon.2023.e20425.
Cancer prevalence, incidence, and mortality rates in Afghanistan in 2020: A review study.
Shayan N, Rahimi A, Ozcebe H
Cancer Rep (Hoboken). 2023; 6(9):e1873.
PMID: 37574721
PMC: 10480416.
DOI: 10.1002/cnr2.1873.
Identifying the Environmental Determinants of Lung Cancer: A Case Study of Henan, China.
Liu Y, Xu Y, Li Y, Wei H
Geohealth. 2023; 7(6):e2023GH000794.
PMID: 37275567
PMC: 10234758.
DOI: 10.1029/2023GH000794.
Dose-response relationship between active smoking and lung cancer mortality/prevalence in the Chinese population: a meta-analysis.
Ai F, Zhao J, Yang W, Wan X
BMC Public Health. 2023; 23(1):747.
PMID: 37095476
PMC: 10124028.
DOI: 10.1186/s12889-023-15529-7.
[Research Progress of DNA Methylation in Cisplatin Resistance in Lung Cancer].
Sun J, Chen J
Zhongguo Fei Ai Za Zhi. 2023; 26(1):52-58.
PMID: 36792081
PMC: 9987084.
DOI: 10.3779/j.issn.1009-3419.2023.101.03.
Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.
Liu X, Chen W, Qi Y, Zhu Y
Evid Based Complement Alternat Med. 2022; 2022:5702014.
PMID: 36159563
PMC: 9492367.
DOI: 10.1155/2022/5702014.
Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC.
Chen P, Wang X, Zhu S, Li H, Rui M, Wang Y
Front Public Health. 2022; 10:956792.
PMID: 36016894
PMC: 9395965.
DOI: 10.3389/fpubh.2022.956792.
Burden of Lung Cancer Attributable to Occupational Carcinogens from 1990 to 2019 and Projections until 2044 in China.
Fan Y, Jiang Y, Li X, Li X, Li Y, Wu H
Cancers (Basel). 2022; 14(16).
PMID: 36010878
PMC: 9405822.
DOI: 10.3390/cancers14163883.
Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030.
Fang Y, Li Z, Chen H, Zhang T, Yin X, Man J
J Cancer Res Clin Oncol. 2022; 149(7):3209-3218.
PMID: 35904601
DOI: 10.1007/s00432-022-04217-5.
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update.
Lu J, Chu T, Liu H, Hu M, Lou Y, Zhang Y
Chin J Cancer Res. 2022; 34(1):28-39.
PMID: 35355930
PMC: 8913254.
DOI: 10.21147/j.issn.1000-9604.2022.01.03.
[Analysis on the Incidence and Economic Burden of Patients with Lung Cancer].
Tian G, Bian L, Xu X, Li S
Zhongguo Fei Ai Za Zhi. 2022; 25(3):167-173.
PMID: 35340159
PMC: 8976202.
DOI: 10.3779/j.issn.1009-3419.2022.101.09.
Health-Related Quality of Life and Utility Scores of Lung Cancer Patients Treated with Traditional Chinese Medicine in China.
Liu L, Wei Y, Teng Y, Yan J, Li F, Chen Y
Patient Prefer Adherence. 2022; 16:297-306.
PMID: 35153476
PMC: 8824292.
DOI: 10.2147/PPA.S344622.
Clinical Significance of Serum-Derived Exosomal LINC00917 in Patients With Non-Small Cell Lung Cancer.
Xiong D, Wang C, Yang Z, Han F, Zhan H
Front Genet. 2022; 12:728763.
PMID: 35003204
PMC: 8739916.
DOI: 10.3389/fgene.2021.728763.